Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on March 17, 2020, covering events occurring on March 15 and March 16, 2020. The filing addresses changes to the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Resignation: Stephen G. Austin resigned as a member of the Board of Directors effective immediately on March 15, 2020. The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
- Appointment: On March 16, 2020, the Board appointed Teresa Sparks to fill the vacancy created by Mr. Austin's resignation. Ms. Sparks will serve until the 2020 Annual Meeting of Stockholders.
- Committee Assignments: Ms. Sparks is an independent director and will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees, including serving as Chair of the Audit Committee.
Guidance, Outlook, and Compensation
There is no guidance, outlook, or management commentary regarding financial performance in this filing. Regarding compensation, Ms. Sparks will receive the Company's standard director's compensation package (cash and equity) and an initial award of 10,000 restricted stock units vesting one year from the grant date.
Key Facts for Investor Verification
- Verify the effective date of Stephen G. Austin's resignation (March 15, 2020).
- Confirm Teresa Sparks' new role as an independent director and Chair of the Audit Committee.
- Note the grant of 10,000 restricted stock units to Ms. Sparks with a one-year vesting schedule.
- Confirm that the resignation was not caused by any disagreement with the Company.